Krebs Biochemicals & Industries Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 7.14 | 8.81 | 7.28 |
| Operating Expense | 6.16 | 7.68 | 6.98 |
| Net Profit | -2.48 | -2.34 | -3.13 |
| Net Profit Margin | -34.73% | -26.56% | -42.99% |
| Earning Per Share | -1.15 | -1.09 | -1.45 |
| EBIDTA | 0.99 | 1.14 | 0.29 |
| Effective Tax Rate | 0% | 0% | 0% |
Particulars
Jun 2026
Revenue7.14
Operating Expense6.16
Net Profit-2.48
Net Profit Margin-34.73
Earning Per Share-1.15
EBIDTA0.99
Effective Tax Rate0
